Importantly, mutant NRAS alone did not reach statistical significance as an independent factor impacting OS or AML-FS.
← all excerpts
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.
1
—
—
Importantly, mutant NRAS alone did not reach statistical significance as an independent factor impacting OS or AML-FS.